Stimoxygen
Develops oxygen-generating nanoparticles for cancer treatment research and therapeutic applications
Highlights
- New on EvolcAdded 2026-11-13
About Stimoxygen
StimOxyGen develops a pH-sensitive nanoparticle formulation designed to release oxygen in hypoxic solid tumours. The polymer coating can also carry additional therapeutic payloads.
The company was co-founded in 2021 and is based in Belfast, Northern Ireland. Its team includes scientists and engineers working on research and development of the technology.
Product: A pH-sensitive nanoparticle formulation that transiently generates oxygen in hypoxic tumours and can carry additional therapeutic payloads.
Jobs at Stimoxygen
Leadership
- Sian Farrell · Chief Executive OfficerSource: company website
More biotech & pharma companies
Stirling Anglian Pharmaceuticals
Develops and supplies specialty branded medicines for UK healthcare providers and NHS stakeholdersStorm Therapeutics
Clinical-stage biotech developing small-molecule RNA modifying enzyme inhibitors for cancer and other diseasesStrameno
Develops marine microorganism strains producing DHA and carotenoids for food, feed and nutraceutical applicationsNew on EvolcStratosvir
Develops engineered viral immunotherapies for solid tumours and their metastases, aiming at cancer patientsNew on EvolcStream Bio
Develops and manufactures fluorescent bioimaging probes for life science research, diagnostics and therapeutic researchNew on EvolcSulantrix
Small-molecule drug discovery targeting pseudokinase ("zombie" protein) classes for hard-to-treat diseasesYoung companyNew on Evolc
Website technologies
Tools and platforms detected on this company’s website, grouped by purpose. Dates record when Evolc observed them.
Backend
- PHPHigh confidence
- First detected
- Last detected
- Last checked
Detection evidence
- Response headerx-powered-by
- Response headerx-powered-by
- Response headerx-powered-by
Content management
- ElementorHigh confidence
- First detected
- Last detected
- Last checked
Detection evidence
- Website resourcedeclared script/iframe or software asset
- WordPressHigh confidence
- First detected
- Last detected
- Last checked
Detection evidence
- Website resourcedeclared script/iframe or software asset
Frontend frameworks
- jQueryHigh confidence
- First detected
- Last detected
- Last checked
Detection evidence
- Website resourcedeclared script/iframe or software asset
Hosting
- LiteSpeedHigh confidence
- First detected
- Last detected
- Last checked
Detection evidence
- Response headerserver
- Response headerserver
- Response headerserver
Website detection does not establish a paid subscription or company-wide use. Tools loaded after consent or sign-in may be missed. “No longer observed” does not prove the company stopped using a tool.